AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5
slide-6

Diabend-MEX 60 Tablet ER

Prescription Icon
Prescription Required

Marketer

Bal Pharma Ltd

Salt Composition

Gliclazide (60mg) + Metformin (500mg)

Overview Diabend-MEX 60 Tablet ER

GlucoDuo 60mg Extended-Release tablets are antidiabetic medications combining two active ingredients to manage type 2 diabetes in adults. These tablets help regulate blood glucose levels. GlucoDuo 60mg ER should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood glucose response. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Maintain regular mealtimes and carry readily available glucose sources (e.g., sugary snacks or juice) to counter hypoglycemia. Alcohol consumption increases hypoglycemia risk and should be limited. Other possible side effects are altered taste, nausea, diarrhea, abdominal pain, headache, upper respiratory infections, and weight gain. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (including complete blood count and liver function tests) are recommended.

Uses of Diabend-MEX 60 Tablet ER

Non-insulin-dependent diabetes

Major Benefits of Diabend-MEX 60 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Diabend-MEX 60 ER tablets. Ingest the tablets whole; do not crush, chew, or divide them. Consume with a meal.

Common Side effects of Diabend-MEX 60 Tablet ER:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Diabend-MEX 60 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; do not chew, crush, or divide it. Consume Diabend-MEX 60 Tablet ER with a meal.

How Diabend-MEX 60 Tablet ER works:

Diabend-MEX 60 Extended-Release tablets contain gliclazide and metformin, two medications used to manage diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Diabend-MEX 60 Tablet ER and alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Diabend-MEX 60 ER tablets is contraindicated during pregnancy due to established risks to the fetus. Exceptional circumstances involving life-threatening conditions may warrant prescription by a physician when potential benefits outweigh identified hazards. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Diabend-MEX 60 tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Diabend-MEX 60 Tablet ER cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult your physician. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Diabend-MEX 60 Tablet ER cautiously, potentially requiring dose modification. Consultation with a physician is advisable. A low starting dose is typically recommended for those with mild to moderate liver disease; however, it's contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Diabend-MEX 60 Tablet ER :

Should you forget a Diabend-MEX 60 Tablet ER dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Diabend-MEX 60 Tablet ER

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Diabend-MEX 60 Tablet ER

Diabend-MEX 60 ER tablets contain gliclazide and metformin, a dual-action medication for managing type 2 diabetes mellitus in adults. This therapy enhances blood sugar control when coupled with a healthy diet and regular physical activity. Gliclazide stimulates insulin secretion from the pancreas, reducing blood glucose. Metformin concurrently decreases hepatic glucose production and increases insulin responsiveness. This formulation is unsuitable for type 1 diabetes.
Diabend-MEX 60 Tablet ER may cause frequent side effects such as low blood sugar (hypoglycemia), changes in taste perception, nausea, abdominal discomfort, loose stools, headaches, and upper respiratory illnesses. Rare but potentially severe adverse reactions, including lactic acidosis, can occur. Prolonged treatment might result in a vitamin B12 deficiency.
Diabend-MEX 60 Tablet ER can induce hypoglycemia, characterized by low blood glucose. Manifestations of this condition may encompass nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. The risk increases with missed or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Having readily available glucose tablets, honey, or fruit juice is recommended.
Diabend-MEX 60 Tablet ER can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is an uncommon adverse effect of metformin. Risk factors include pre-existing kidney impairment, advanced age, and high alcohol consumption. Symptoms may involve muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal discomfort, or a slow pulse. If these symptoms appear, discontinue Diabend-MEX 60 Tablet ER and seek immediate medical attention.
Prolonged Diabend-MEX 60 Tablet ER use can indeed lead to vitamin B12 deficiency. This is because the medication impedes the stomach's absorption of vitamin B12. Untreated deficiency may result in anemia, neurological issues such as tingling and numbness in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and gait instability. Preventive measures, proposed by some studies, include annual supplemental vitamin B12 intake.
Diabend-MEX 60 Tablet ER is contraindicated for individuals with hypersensitivity to any of its constituents or inactive ingredients. Its use is also prohibited in patients experiencing moderate to severe renal impairment or those with pre-existing metabolic acidosis, such as diabetic ketoacidosis.
Combining Diabend-MEX 60 Tablet ER and alcohol is unsafe. This combination can dangerously reduce blood sugar levels, increasing the risk of lactic acidosis.
Diabend-MEX 60 ER tablets contain gliclazide and metformin, two medications used together to manage type 2 diabetes mellitus in adults. This dual-drug therapy, when combined with a healthy diet and regular physical activity, helps control blood sugar. Gliclazide's mechanism involves stimulating insulin secretion from the pancreas, while metformin reduces hepatic glucose production and enhances insulin responsiveness. This formulation is unsuitable for treating type 1 diabetes.
Diabend-MEX 60 Tablet ER may cause common adverse reactions such as low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal discomfort, diarrhea, headache, and upper respiratory infections. Rare but potentially severe side effects include lactic acidosis. Prolonged use might result in vitamin B12 deficiency.
Diabend-MEX 60 Tablet ER can induce hypoglycemia, characterized by low blood sugar. Manifestations of this condition include nausea, headache, irritability, hunger pangs, sweating, dizziness, tachycardia, and feelings of anxiety or tremor. The likelihood increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is recommended.
Diabend-MEX 60 Tablet ER use can result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed metformin-associated lactic acidosis (MALA), this is an uncommon adverse reaction to metformin. Risk factors include pre-existing kidney impairment, advanced age, and high alcohol consumption. Symptoms may manifest as muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, or bradycardia. If these symptoms appear, discontinue Diabend-MEX 60 Tablet ER and seek immediate medical attention.
Prolonged Diabend-MEX 60 Tablet ER administration can indeed lead to vitamin B12 insufficiency. This is because the medication impedes the stomach's absorption of vitamin B12. Left unaddressed, this deficiency might result in anemia, neurological complications, including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive impairment, and gait instability. To mitigate these risks, supplemental vitamin B12 intake, at a minimum annually, has been proposed by some investigators.
Patients with a history of hypersensitivity to Diabend-MEX 60 Tablet ER constituents or inactive ingredients should not use this medication. Its use is also contraindicated in individuals with moderate to severe renal impairment or pre-existing metabolic acidosis, such as diabetic ketoacidosis.
Combining Diabend-MEX 60 Tablet ER and alcohol is unsafe. This combination risks dangerously low blood sugar and raises the likelihood of lactic acidosis.
Diabend-MEX 60 Tablet ER
144
MRP 175
17% off